• 1
    Holick M F. Evolution and function of vitamin D. Recent Results Cancer Res 2003: 164: 328.
  • 2
    Henry H L. Vitamin D hydroxylase. J Cell Biochem 1992: 49: 49.
  • 3
    Nebert D W, Gonzalez F J. P450 genes: structure, evolution, and regulation. Ann Rev Biochem 1987: 56: 945993.
  • 4
    Jones G, Ramshaw H, Zhang A et al. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1a and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 1999: 140: 33033310.
  • 5
    Lehmann B, Querings K, Reichrath J. Vitamin D and skin: new aspects for dermatology. Exp Dermatol 2004: 13 (Suppl. 4): 1115.
  • 6
    Reichrath J, Rafi L, Rech M et al. Analysis of the vitamin D system in cutaneous squamous cell carcinomas (SCC). J Cut Pathol 2004: 31: 224231.
  • 7
    Reichrath J, Schuler Ch, Seifert M, Zouboulis Ch, Tilgen W. The vitamin D endocrine system of human sebocytes. Exp Dermatol 2006: 15: 643.
  • 8
    Tangpricha V, Flanagan J N, Whitlatch L W et al. 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue. Lancet 2001: 357: 16731674.
  • 9
    Pillai S, Bikle D D, Elias P M. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem 1988: 263: 53905395.
  • 10
    Fu G K, Lin D, Zhang M Y et al. Cloning of human 25-hydroxyvitamin D-1alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997: 11: 19611970.
  • 11
    May E, Asadullah K, Zügel U. Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs. Curr Drug Targets Inflamm Allergy 2004: 3: 377393.
  • 12
    Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A 2006: 103: 1173611741.
  • 13
    Ravid A, Rubinstein E, Gamady A, Rotem C, Liberman U A, Koren R. Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J Endocrinol 2002: 173: 525532.
  • 14
    Diker-Cohen T, Koren R, Liberman U A, Ravid A. Vitamin D protects keratinocytes from apoptosis induced by osmotic shock, oxidative stress, and tumor necrosis factor. Ann N Y Acad Sci 2003: 1010: 350353.
  • 15
    Tilgen W, Rass K, Reichrath J. 30 Jahre dermatologische Onkologie. Akt Dermatol 2005: 31: 7988.
  • 16
    Rass K. UV-damage and DNA-repair in basal and squamous cell carcinomas. In: ReichrathJ, ed. Molecular Mechanisms of Basal Cell and Squamous Cell Carcinomas. Georgetown, USA: Landes Bioscience, in press.
  • 17
    De Haes P, Garmyn M, Verstuyf A et al. Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB. Arch Dermatol Res 2004: 12: 527534.
  • 18
    De Haes P, Garmyn M, Carmeliet G et al. Molecular pathways involved in the anti-apoptotic effect of 1,25-dihydroxyvitamin D3 in primary human keratinocytes. J Cell Biochem 2004: 93: 951967.
  • 19
    De Haes P, Garmyn M, Degreef H, Vantieghem K, Bouillon R, Segaert S. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem 2003: 89: 663673.
  • 20
    Wong G, Gupta R, Dixon K M et al. 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway. J Steroid Biochem Mol Biol 2004: 89–90: 567570.
  • 21
    De Haes P, Garmyn M, Verstuyf A et al. 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B 2005: 78: 141148.
  • 22
    Gombard H F, Borregaard N, Koeffler H P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Faseb J 2005: 19: 10671077.
  • 23
    Wang T-T, Nestel F P, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004: 173: 29092912.
  • 24
    Weber G, Heilborn J D, Chamorro Jimenez C I, Hammarsjö A, Törmä H, Ståhle M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005: 124: 10801082.
  • 25
    Liu P T, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006: 311: 17701773.
  • 26
    Schauber J, Dorschner R A, Coda A B et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007: 117: 803811.
  • 27
    Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004: 75: 3948.
  • 28
    Zaiou M, Nizet V, Gallo R L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 2003: 120: 810816.
  • 29
    Frohm Nilsson M, Sandstedt B, Sørensen O, Weber G, Borregaard N, Ståhle-Bäckdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999: 67: 25612566.
  • 30
    Dorschner R A, Pestonjamasp V K, Tamakuwala S et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001: 117: 9197.
  • 31
    Heilborn J D, Nilsson M F, Kratz G et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003: 120: 379389.
  • 32
    Cannell J J, Vieth R, Umhau J C et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006: 7: 112.
  • 33
    Schwartz G G, Whitlatch L W, Chen T C, Lokeshwar B L, Holick M F. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prev 1998: 7: 391395.
  • 34
    Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005: 16: 8395.
  • 35
    Garland C F, Comstock G W, Garland F C et al. Serum 25-hydroxyvitamin D and colon cancer: eight year prospective study. Lancet 1989: 2: 11761178.
  • 36
    Holick M F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004: 80 (Suppl. 6): 1678S1688S.
  • 37
    Gorham E D, Garland F C, Garland C F. Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 1990: 19: 614622.
  • 38
    Grant W B. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002: 94: 18671875.
  • 39
    Berwick M, Kesler D. Ultraviolet radiation exposure, vitamin D, and cancer. Photochem Photobiol 2005: 81: 12611266.
  • 40
    Hoffman F. The Mortality of Cancer Throughout the World, (Appendix E). Newark, NJ: Prudential Press, 1915.
  • 41
    Peller S. Carcinogenesis as a means of reducing cancer mortality. Lancet 1936: 2: 552556.
  • 42
    Apperly F L. The relation of solar radiation to cancer mortality in North America. Cancer Res 1941: 1: 191195.
  • 43
    Berwick M, Armstrong B K, Ben-Porat L et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005: 97: 195199.
  • 44
    Moan J, Porojnicu A C, Robsahm T E et al. Solar radiation, vitamin D and survival rate of colon cancer in Norway. J Photochem Photobiol B 2005: 78: 189193.
  • 45
    Grant W B. The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survival. Anticancer Res 2006: 26: 26052614.
  • 46
    Zhou W, Suk R, Liu G et al. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2005: 14: 23032309.
  • 47
    Querings K, Girndt M, Geisel J, Georg T, Tilgen W, Reichrath J. 25-Hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab 2006: 91: 526529.
  • 48
    Querings K, Reichrath J. A plea for detection and treatment of vitamin D deficiency in patients under photoprotection, including patients with xeroderma pigmentosum and basal cell nevus syndrome. Cancer Causes Control 2004: 15: 219.
  • 49
    Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999: 69: 842856.
  • 50
    Bischoff-Ferrari H A, Giovannucci E, Willett W C, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006: 84: 1828.
  • 51
    Gorham E D, Garland C F, Garland F C et al. Optimal vitamin D status for colorectal cancer prevention a quantitative meta analysis. Am J Prev Med 2007: 32: 210216.
  • 52
    Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006: 92: 2632.
  • 53
    Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006: 136: 11171122.
  • 54
    Dawson-Hughes B, Heaney R P, Holick M F, Lips P, Meunier P J, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005: 16: 713716.
  • 55
    Holick M F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004: 79: 362371.
  • 56
    Barger-Lux M J, Heaney R P, Dowell S, Chen T C, Holick M F. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 1998: 8: 222230.
  • 57
    Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004: 89–90: 575579.
  • 58
    Reichrath J. The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer? Prog Biophys Mol Biol 2006: 92: 916.
  • 59
    Holick M F. Sunlight ‘D'ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 2001: 357: 961.
  • 60
    Webb A R, Kline L, Holick M F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988: 67: 373378.
  • 61
    British Pediatric Association. Hypercalcemia in infants and vitamin D. BMJ 1956: 2: 149.
  • 62
    Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis C C. Vitamins as hormones. Horm Metab Res 2007: 39: 7184.